MedPath

Esophageal Multisegmented FCSEMS for Malignant Strictures

Not Applicable
Terminated
Conditions
Oesophageal Cancer
Esophageal Stent Stenosis
Interventions
Device: Multisegmented fully covered self-expandable metal stent
Registration Number
NCT04415463
Lead Sponsor
Radboud University Medical Center
Brief Summary

Objective: To assess the safety and feasibility of the implementation of the esophageal multisegmented fully covered self-expandable metal stent (SEMS) for the palliation of patients with malignant dysphagia.

Study design: Prospective observational nonrandomized clinical study.

Study population: A total of 30 patients with malignant dysphagia will be included. Sample size calculation does not apply for this type of study.

Intervention: All patients will be treated with the esophageal multisegmented fully covered SEMS.

Primary end points:

* Safety: complications and adverse events during follow-up with special attention to stent migration rates;

* Efficacy: technical success of stent placement.

Secondary end points:

* Recurrent dysphagia including its cause;

* Functional outcome: Ogilvie dysphagia score and WHO performance score (measured at baseline, 2 weeks and every 4 weeks until death/stent removal, or until a maximum of 6 months follow-up);

* Tissue ingrowth or overgrowth (measured endoscopically every endoscopic evaluation during follow-up);

* Pain related to esophageal stent.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
23
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
FC-SEMSMultisegmented fully covered self-expandable metal stentPlacement of multisegmented fully covered self-expandable metal stent
Primary Outcome Measures
NameTimeMethod
Adverse events6 months

Adverse events during follow-up

Technical success of stent placement1 day

Technical success of stent placement

Secondary Outcome Measures
NameTimeMethod
Recurrent dysphagia6 months

Ogilvie dysphagia score

Functional outcome6 months

WHO performance score

Tissue ingrowth or overgrowth6 months
Pain related to esophageal stent6 months

Measured using the Visual Analogue Scale (VAS)

Trial Locations

Locations (1)

Radboudumc

🇳🇱

Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath